Clinical Trials Directory

Trials / Completed

CompletedNCT00450775

Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Innovative Medical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the efficacy and patient acceptance of Dermatix Q for the prevention and treatment of scarring.

Conditions

Interventions

TypeNameDescription
DRUGDermatix QDermatix Q applied twice daily

Timeline

Start date
2007-03-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2007-03-22
Last updated
2008-09-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00450775. Inclusion in this directory is not an endorsement.

Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scar (NCT00450775) · Clinical Trials Directory